Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07597278 · ClinicalTrials.gov registry record
Quantra QPlus in Pediatric Cardiovascular Procedures
A clinical trial, sponsored by HemoSonics.
- Not yet
- Registry status
- 160
- Enrollment target
NCT07597278: Clinical Trial study, sponsored by HemoSonics.
NCT07597278 is a clinical trial that has not yet begun recruiting, run by HemoSonics. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07597278 has not yet begun recruiting, sponsored by HemoSonics.
- NOT YET RECRUITING
- Registry status
- 160 participants
- Enrollment target
Study Summary
This study will evaluate the performance of the Quantra System with the QPlus Cartridge in pediatric patients undergoing cardiovascular procedures.
Primary Outcome
Coagulation function assessed by Quantra and ROTEM sigma
Interventions
- DIAGNOSTIC_TEST Quantra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-09-25 |
| Est. Completion | 2027-10-15 |
What is known before NCT07597278 opens enrollment
NCT07597278 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quantra System is the first listed.
NCT07597278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07597278 about?
NCT07597278 is a clinical study titled "Quantra QPlus in Pediatric Cardiovascular Procedures". This study will evaluate the performance of the Quantra System with the QPlus Cartridge in pediatric patients undergoing cardiovascular procedures.
What is the current status of trial NCT07597278?
This trial is currently not yet recruiting. The enrollment target is 160 participants. The study started on 2026-09-25. Estimated completion is 2027-10-15.
What interventions are being tested in trial NCT07597278?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07597278?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI